Acadia Pharmaceuticals ACAD Total costs & expenses

Total costs & expenses at other companies

BiogenBIIB

$2.6B+36.9%

Zevra Therapeutics, Inc.ZVRA

$21.05M-13.1%

Neurocrine BiosciencesNBIX

——

FAQ

What is Acadia Pharmaceuticals's total costs & expenses?

Acadia Pharmaceuticals (ACAD) reported total costs & expenses of $270.12M in Q2 2026.

How has Acadia Pharmaceuticals's total costs & expenses changed year-over-year?

Acadia Pharmaceuticals's total costs & expenses increased by 16.3% year-over-year, from $232.19M to $270.12M.

What is the long-term trend for Acadia Pharmaceuticals's total costs & expenses?

Over 4 years (2021 to 2025), Acadia Pharmaceuticals's total costs & expenses has grown at a 10.2% compound annual growth rate (CAGR), from $654.58M to $966.69M.

What does total costs & expenses mean?

This metric represents the aggregate of all operating and non-operating costs incurred by the company to support its business activities during a specific period. It encompasses the sum of cost of goods sold, research and development investments, and selling, general, and administrative expenses. Monitoring this figure allows investors to evaluate the company's overall cost structure and operational efficiency relative to its revenue generation.